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At 18, Kruchten took a summer job washing dishes in a laboratory at Indiana University in her hometown of Indianapolis. Her future was planned. She would attend Transylvania 
University (home of the Pioneers, not the vampires, she 
notes with a laugh) in Lexington, Ky., and then head to 
medical school.
 But that summer her focus slowly began to shift. 
The lab became more than just another summer job and 
she took her first tentative steps into research, which 
started as a challenge from the lab director.
 “He gave me two pieces of paper and said I need-
ed to learn every piece of equipment listed,” she said. 
“I think it was a sink or swim test, but within a week 
I finished everything and I started to do research.” 
 It’s a lesson she has not forgotten and she follows 
the same philosophy with her Linfield students. “I start 
out with some hand holding to get them used to the 
process, but in the end, they are on their own,” she said.
 After four summers in the lab at Indiana, medical 
school was set aside and she headed to graduate school. 
Five years later, Ph.D. in hand, she began a postdoctoral 
program at the Mayo Clinic in Rochester, Minn., where 
she switched her research focus from obesity and diabe-
tes to cancer. 
 Kruchten, an assistant professor of biology at Lin-
field for three years, is tall with a head of brown, curly 
hair that bounces around her face. She is quick to laugh, 
 Cancer is more than a disease to Anne Kruchten.
 She considers it from an analytical, clinical and scientific perspective, but 
at the end of the day, it is personal. What drives her is the need to understand 
why her brother died in his early 20s of a rare and deadly form of bone cancer 
and what can be done to stop it. Her research has become an integral part of 
her classroom as well as an important component in the lives of students who 
work by her side in Linfield laboratories.
Searching 
for a cure 
for cancer
Cortactin, highlighted in bright green masses along the edges of the cells, is suspected to play a role in how malignant cells move 
throughout the body.
has a good arm in softball and a knack for explaining 
complicated research. She can be intense, demanding 
and funny, and students love her. 
 Jeneva Foster ’09 is pursuing a Ph.D. program in 
biochemistry, molecular and cell biology at the Univer-
sity of Oregon. Her work with Kruchten helped her 
learn how to think like a researcher and define her goals. 
She not only worked in Kruchten’s Linfield lab, she also 
learned about writing research papers and grants, which 
also helped prepare her for graduate school. 
 “Working in a research lab is different than the 
labs you do for class,” she said. “You don’t blindly follow 
the protocol the professor printed out; you have to re-
ally think about and understand what you are doing and 
why you are doing it.
 “Before I started working with Anne, I didn’t know 
what I wanted to do and I doubted myself all the time,” 
Foster added. “She is one of the biggest reasons I’m [at 
UO]. She always challenges you, but never discourages 
you. She helps you find the answers without telling you 
what they are.”
Understanding cortactin
 A nanometer-sized protein called cortactin lies at 
the center of Kruchten’s work, research that began dur-
ing her post-doctoral studies at the Mayo Clinic. She 
and her students are trying to determine the role cort-
actin plays in how cancer metastasizes, when malignant 
cells break off from a primary tumor and travel through 
blood vessels.
  “People die from cancer because tumor cells mi-
grate to other places in the body and disrupt organ func-
tion,” she said. Understanding this movement, or metas-
tasis, is at the heart of her research. 
 Some cancers are far more metastatic than oth-
ers. For example, skin cancer can be relatively metastatic. 
Some forms of breast cancer can be much more so and 
pancreatic and bone cancer are highly metastatic. Cort-
Cancer and heart disease
 Cancer is the second leading cause of death in 
the United States, after heart disease. 
 Headway has been made to address heart dis-
ease, but similar advances have not been made in 
reducing cancer deaths.
 There are reasons for that, according to Anne 
Kruchten. Heart disease is not just one disease, but 
it’s a few things affecting one organ. Once you fig-
ure out what’s going on with the heart, it is easier to 
determine how to treat it.
 In contrast, there are many types of cancer all 
working in different ways. For example, in one tu-
mor, every cell can be different. Research has been 
segmented to address different aspects of cancer. 
There is a move to create consortia so that informa-
tion on, for example, cell migration, is funneled into 
one website so no one is working in isolation.
 Discussion at a conference Kruchten attended 
focused on how small colleges fit into the consortia. 
 “We can’t be the front runners, but we can do 
the little bits big labs don’t care about, but which are 
important parts of the puzzle,” she said. “That’s how 
small schools and undergraduate researchers can be 
effective. It involves little things that are key compo-
nents to finding out the answers.”
Anne Kruchten, assistant professor of biology, completed her 
Ph.D. in biochemistry, molecular biology and biophysics. Her 
broad training is helpful at Linfield because she has experience 
in everything from very fine molecular biology all the way to 
intensive crystallography and biophysics.
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actin is involved in trafficking proteins in normal cells, 
making sure that cells get where they are supposed to be. 
Kruchten’s hypothesis is that a modified form of cortac-
tin is also involved in moving malignant cells to different 
parts of the body.
 Kruchten made some progress during her research 
at the Mayo Clinic, showing that one pool of modified 
cortactin might push the cell forward, and a second, dif-
ferent pool helps to retract it, much as an inchworm 
moves forward – when the front moves ahead, the rear 
has to retract. Now her students are following up on 
that work. 
 In her second day in the lab last summer, Kath-
erine Arns ’11 made the unexpected discovery that she 
could isolate pools of cortactin using a simple separation 
method. She spent the summer working to make sense 
of this finding.
 “It was very exciting, and it changed my entire 
summer project for the better,” said Arns, who learned 
valuable laboratory techniques and became well versed 
in a protein she’d never heard of before.
 Learning the structure of cortactin is essential in 
trying to understand how it might react. The structure 
of the protein cannot be photographed because, unlike 
some proteins which form a repeating pattern, cortactin 
doesn’t form the same shape every time. 
 “If I could get a picture of the structure, it would 
help me understand what it will do,” Kruchten said. 
“Without an understanding of the structure, it’s harder 
to predict how it will function.”
On choosing a major 
 Anne Kruchten understands being uncertain 
about a major.
 When she enrolled in Transylvania University, 
she was a premed major. Then she changed to biology 
and spent a week as a chemistry major, before giving 
up on the hard sciences. She was a psychology major 
for a semester, then a Spanish major before completing 
the circle and earning her bachelor’s in biology.
 When it came time to apply to graduate schools, 
she was looking for a mentor who would allow her to 
be independent. She chose the University of Minnesota, 
where her research focused on obesity and diabetes. 
 When she was investigating postdoctoral pro-
grams, she wanted to conduct cancer research and 
needed skills that she hadn’t picked up in her gradu-
ate program. The Mayo Clinic offered the opportu-
nity to work in an intensive cell biology and micros-
copy cancer lab – the best of both worlds.
 “Minnesota is very much an academic institu-
tion, so you get to see the academic side of labora-
tory work,” she said. “Mayo is extremely medical, 
very clinical and the lab space is more focused on 
clinical studies.” 
Looking for evidence
 Sarah Click ’11 hunches 
over a microscope with a 
built-in camera. 
 She inserts slides of cells 
and takes photos that magnify 
the cells 100 times. Click is try-
ing to determine whether cells 
that are highly metastatic show 
an elevated concentration of 
cortactin. If it plays a role in helping malignant cells 
move, there should be high levels of the protein along 
the edges of cells. 
 Once she has the photos of the new cells, she 
shifts to the computer, pulls up the shots and begins 
isolating the cells that best illustrate her project. She 
spent hours in a biology lab, shooting hundreds of 
photos, then sharpening the images.
 Click’s research with Anne Kruchten will deter-
mine her future – either medical school or graduate 
school. She calls Kruchten patient and approachable.
 “She took the time to make sure I under-
stood all the science and the significance of what 
I was doing in the laboratory and answered my 
questions thoroughly,” Click said. “It was a really 
positive learning experience and a way for me to 
work toward some of my career goals.” 
 She and Brian Gilbert, associate professor of chem-
istry, are hoping to collaborate on a project that could 
help determine the structure of the protein.   
 “Ultimately, we don’t want the cell to metastasize,” 
Kruchten said. “If we can figure out the structure of cort-
actin, we might also figure out how to change that struc-
ture and prevent metastasis. That’s the long-term goal.” 
Research complements teaching
 As passionate as Kruchten is about her research, 
she’s also a committed teacher. She brings research into 
all of her classes, whether it’s an advanced biochemistry 
class with four students, or an introductory principles of 
biology class. 
  “I firmly believe that research should be part of 
teaching, I don’t see them as separate entities,” she said. 
“Biology is an experimental science, it’s not just obser-
vation. And, I like explaining scientific things to people 
who don’t do science.” 
 Kruchten, who also hopes to someday be a science 
writer on the side, is a voracious reader, who is con-
stantly reading articles and researching subjects on the 
Internet. She uses textbooks, but augments her classes 
with articles and projects to keep students engaged, in-
volved and asking questions. In January, she’s leading her 
first off-campus course, “Biogenesis in Italy and France: 
A Historical Perspective on Microbiology Discoveries.” 
 Kruchten’s brief window for focused research – 
10 weeks in the summer – can be frustratingly short, 
Sarah Click ‘11 examines a batch of slides she photographed 
to determine whether high levels of the protein cortactin indicate 
that it plays a role in how cancer cells metastasize. Sometimes the 
results are almost artistic – the bright green cortactin is highlighted 
on the black background. One slide, with hundreds of cells 
sprinkled across it, suggests city lights seen from a plane at night.
but the fact that she and her students continue to make 
progress keeps her going. 
 “I don’t think the students really believe when 
they first come in that they are going to do anything 
worthwhile,” she said. “They might have grand ideas 
that they are going to cure cancer, but I don’t think they 
understand they really can have a part in that.”
 Her students have consistently made headway, col-
lected data and presented findings at national confer-
ences each of the three years she’s been at Linfield. 
 “When they make these presentations they have 
an opportunity to talk to post-doctoral researchers and 
graduate students and they have to defend what they did 
and explain why it contributes to the field,” she added. 
 Combining teaching and research, mentoring 
students and keeping her work fun are all important. 
 “The nice thing about working with undergradu-
ates is that they have a lot of enthusiasm,” she said. “It 
can be monotonous working in the lab, but for students, 
finding their first data is very exciting.”
 The mystery that drives investigative research con-
tinues to intrigue her. 
 “You have to figure out how all these different 
pieces fit together,” she said. “Because you are work-
ing in a test tube, you have to figure out what’s real 
and what happened because you took the protein out 
of the cell. And the hardest part is ‘does this really mean 
anything?’ How do you actually relate this to what 
happens to someone who has cancer? Can it be related? 
That’s the hard part.” �
– Mardi Mileham
F  A  L  L    2  0  0  9   -   2 1
 2 0   -   L  I  N  F  I  E  L  D    M  A  G  A  Z  I  N  E
actin is involved in trafficking proteins in normal cells, 
making sure that cells get where they are supposed to be. 
Kruchten’s hypothesis is that a modified form of cortac-
tin is also involved in moving malignant cells to different 
parts of the body.
 Kruchten made some progress during her research 
at the Mayo Clinic, showing that one pool of modified 
cortactin might push the cell forward, and a second, dif-
ferent pool helps to retract it, much as an inchworm 
moves forward – when the front moves ahead, the rear 
has to retract. Now her students are following up on 
that work. 
 In her second day in the lab last summer, Kath-
erine Arns ’11 made the unexpected discovery that she 
could isolate pools of cortactin using a simple separation 
method. She spent the summer working to make sense 
of this finding.
 “It was very exciting, and it changed my entire 
summer project for the better,” said Arns, who learned 
valuable laboratory techniques and became well versed 
in a protein she’d never heard of before.
 Learning the structure of cortactin is essential in 
trying to understand how it might react. The structure 
of the protein cannot be photographed because, unlike 
some proteins which form a repeating pattern, cortactin 
doesn’t form the same shape every time. 
 “If I could get a picture of the structure, it would 
help me understand what it will do,” Kruchten said. 
“Without an understanding of the structure, it’s harder 
to predict how it will function.”
On choosing a major 
 Anne Kruchten understands being uncertain 
about a major.
 When she enrolled in Transylvania University, 
she was a premed major. Then she changed to biology 
and spent a week as a chemistry major, before giving 
up on the hard sciences. She was a psychology major 
for a semester, then a Spanish major before completing 
the circle and earning her bachelor’s in biology.
 When it came time to apply to graduate schools, 
she was looking for a mentor who would allow her to 
be independent. She chose the University of Minnesota, 
where her research focused on obesity and diabetes. 
 When she was investigating postdoctoral pro-
grams, she wanted to conduct cancer research and 
needed skills that she hadn’t picked up in her gradu-
ate program. The Mayo Clinic offered the opportu-
nity to work in an intensive cell biology and micros-
copy cancer lab – the best of both worlds.
 “Minnesota is very much an academic institu-
tion, so you get to see the academic side of labora-
tory work,” she said. “Mayo is extremely medical, 
very clinical and the lab space is more focused on 
clinical studies.” 
Looking for evidence
 Sarah Click ’11 hunches 
over a microscope with a 
built-in camera. 
 She inserts slides of cells 
and takes photos that magnify 
the cells 100 times. Click is try-
ing to determine whether cells 
that are highly metastatic show 
an elevated concentration of 
cortactin. If it plays a role in helping malignant cells 
move, there should be high levels of the protein along 
the edges of cells. 
 Once she has the photos of the new cells, she 
shifts to the computer, pulls up the shots and begins 
isolating the cells that best illustrate her project. She 
spent hours in a biology lab, shooting hundreds of 
photos, then sharpening the images.
 Click’s research with Anne Kruchten will deter-
mine her future – either medical school or graduate 
school. She calls Kruchten patient and approachable.
 “She took the time to make sure I under-
stood all the science and the significance of what 
I was doing in the laboratory and answered my 
questions thoroughly,” Click said. “It was a really 
positive learning experience and a way for me to 
work toward some of my career goals.” 
 She and Brian Gilbert, associate professor of chem-
istry, are hoping to collaborate on a project that could 
help determine the structure of the protein.   
 “Ultimately, we don’t want the cell to metastasize,” 
Kruchten said. “If we can figure out the structure of cort-
actin, we might also figure out how to change that struc-
ture and prevent metastasis. That’s the long-term goal.” 
Research complements teaching
 As passionate as Kruchten is about her research, 
she’s also a committed teacher. She brings research into 
all of her classes, whether it’s an advanced biochemistry 
class with four students, or an introductory principles of 
biology class. 
  “I firmly believe that research should be part of 
teaching, I don’t see them as separate entities,” she said. 
“Biology is an experimental science, it’s not just obser-
vation. And, I like explaining scientific things to people 
who don’t do science.” 
 Kruchten, who also hopes to someday be a science 
writer on the side, is a voracious reader, who is con-
stantly reading articles and researching subjects on the 
Internet. She uses textbooks, but augments her classes 
with articles and projects to keep students engaged, in-
volved and asking questions. In January, she’s leading her 
first off-campus course, “Biogenesis in Italy and France: 
A Historical Perspective on Microbiology Discoveries.” 
 Kruchten’s brief window for focused research – 
10 weeks in the summer – can be frustratingly short, 
Sarah Click ‘11 examines a batch of slides she photographed 
to determine whether high levels of the protein cortactin indicate 
that it plays a role in how cancer cells metastasize. Sometimes the 
results are almost artistic – the bright green cortactin is highlighted 
on the black background. One slide, with hundreds of cells 
sprinkled across it, suggests city lights seen from a plane at night.
but the fact that she and her students continue to make 
progress keeps her going. 
 “I don’t think the students really believe when 
they first come in that they are going to do anything 
worthwhile,” she said. “They might have grand ideas 
that they are going to cure cancer, but I don’t think they 
understand they really can have a part in that.”
 Her students have consistently made headway, col-
lected data and presented findings at national confer-
ences each of the three years she’s been at Linfield. 
 “When they make these presentations they have 
an opportunity to talk to post-doctoral researchers and 
graduate students and they have to defend what they did 
and explain why it contributes to the field,” she added. 
 Combining teaching and research, mentoring 
students and keeping her work fun are all important. 
 “The nice thing about working with undergradu-
ates is that they have a lot of enthusiasm,” she said. “It 
can be monotonous working in the lab, but for students, 
finding their first data is very exciting.”
 The mystery that drives investigative research con-
tinues to intrigue her. 
 “You have to figure out how all these different 
pieces fit together,” she said. “Because you are work-
ing in a test tube, you have to figure out what’s real 
and what happened because you took the protein out 
of the cell. And the hardest part is ‘does this really mean 
anything?’ How do you actually relate this to what 
happens to someone who has cancer? Can it be related? 
That’s the hard part.” �
– Mardi Mileham
F  A  L  L    2  0  0  9   -   2 1
